Skip to main content

Advertisement

Log in

Serum paraoxonase activity is associated with epicardial fat tissue in renal transplant recipients

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Aims

Cardiovascular disease is a major cause of mortality in renal transplant recipients. Paraoxonase-1 (PON-1) has been shown to protect against atherosclerosis by modifying lipoproteins. Epicardial fat tissue (EFT) has been proposed as a new cardiovascular risk factor. The aim of this study was to investigate the relationship between PON-1 activity and EFT in renal transplant recipients.

Methods

Eighty renal transplant recipients were enrolled in this cross-sectional study. PON-1 activity was assessed from the rate of enzymatic hydrolysis of paraoxon to p-nitrophenol. EFT was measured by echocardiography.

Results

The mean age of the patients was 40.4 ± 12.3 years and mean post transplant follow-up duration was 57.2 ± 46 months. Mean PON-1 activity was 68.5 ± 30 U/L. PON-1 activity was positively correlated with age and body mass index and negatively correlated with parathyroid hormone, dialysis duration and EFT. The mean EFT thickness was 0.64 ± 0.17 cm. Multiple linear regression analysis was used to define independent determinants of EFT in renal transplant recipients. According to linear regression analysis, PON-1 levels and age were found to be independent predictors of EFT.

Conclusion

Reduced PON-1 activity was negatively associated with EFT and PON-1 activity independently predicts EFT in renal transplant recipients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Lentine KL, Hurst FP, Jindal RM, Villines TC, Kunz JS, Yuan CM, Hauptman PJ, Abbott KC (2010) Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies. Am J Kidney Dis 55(1):152–167

    Article  PubMed Central  PubMed  Google Scholar 

  2. Ghanta M, Kozicky M, Jim B (2015) Pathophysiologic and treatment strategies for cardiovascular disease in end-stage renal disease and kidney transplantations. Cardiol Rev 23(3):109–118

  3. Hotta K, Harada H, Sasaki H, Iwami D, Fukuzawa N, Morita K, Seki T, Togashi M, Nonomura K (2012) Successful kidney transplantation ameliorates arterial stiffness in end-stage renal disease patients. Transplant Proc 44(3):684–686

    Article  CAS  PubMed  Google Scholar 

  4. Stompór T, Rajzer M, Kawecka-Jaszcz K, Dembińska-Kieć A, Janda K, Wójcik K, Tabor B, Zdzienicka A, Grzybowska EJ, Sulowicz W (2005) Renal transplantation ameliorates the progression of arterial stiffness in patients treated with peritoneal dialysis. Perit Dial Int 25(5):492–496

    PubMed  Google Scholar 

  5. Delahousse M, Chaignon M, Mesnard L, Boutouyrie P, Safar ME, Lebret T, Pastural-Thaunat M, Tricot L, Kolko-Labadens A, Karras A, Haymann JP (2008) Aortic stiffness of kidney transplant recipients correlates with donor age. J Am Soc Nephrol 19(4):798–805

    Article  PubMed Central  PubMed  Google Scholar 

  6. Kneifel M, Scholze A, Burkert A, Offermann G, Rothermund L, Zidek W, Tepel M (2006) Impaired renal allograft function is associated with increased arterial stiffness in renal transplant recipients. Am J Transplant 6(7):1624–1630

    Article  CAS  PubMed  Google Scholar 

  7. Rosenblat M, Volkova N, Aviram M (2011) Injection of paraoxonase 1 (PON1) to mice stimulates their HDL and macrophage antiatherogenicity. Biofactors 37(6):462–467

    Article  CAS  PubMed  Google Scholar 

  8. Tang WH, Hartiala J, Fan Y, Wu Y, Stewart AF, Erdmann J, Kathiresan S, CARDIoGRAM Consortium, Roberts R, McPherson R, Allayee H, Hazen SL (2012) Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk. Arterioscler Thromb Vasc Biol 32(11):2803–2812

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Dantoine TF, Debord J, Charmes JP, Merle L, Marquet P, Lachatre G, Leroux-Robert C (1998) Decrease of serum paraoxonase activity in chronic renal failure. J Am Soc Nephrol 9(11):2082–2088

    CAS  PubMed  Google Scholar 

  10. Sztanek F, Seres I, Harangi M, Lőcsey L, Padra J, Paragh GJ, Asztalos L, Paragh G (2012) Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease. Nephrol Dial Transplant 27(7):2866–2872

    Article  CAS  PubMed  Google Scholar 

  11. Gungor O, Kismali E, Sisman AR, Kircelli F, Asci G, Topal K, Sipahi S, Tuncel P, Ozkahya M, Toz H (2013) The associations between serum paraoxonase 1 activity and carotid atherosclerosis in renal transplant patients. Clin Nephrol 80(3):198–202

    Article  CAS  PubMed  Google Scholar 

  12. Iacobellis G, Corradi D, Sharma AM (2005) Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2(10):536–543

    Article  PubMed  Google Scholar 

  13. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, Sarov-Blat L, O’Brien S, Keiper EA, Johnson AG, Martin J, Goldstein BJ, Shi Y (2003) Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108(20):2460–2466

    Article  PubMed  Google Scholar 

  14. Katsiki N, Mikhailidis DP, Wierzbicki AS (2013) Epicardial fat and vascular risk: a narrative review. Curr Opin Cardiol 28(4):458–463

    Article  PubMed  Google Scholar 

  15. Turan MN, Gungor O, Asci G, Kircelli F, Acar T, Yaprak M, Ceylan N, Demirci MS, Bayraktaroglu S, Toz H, Ozkahya M, Ok E (2013) Epicardial adipose tissue volume and cardiovascular disease in hemodialysis patients. Atherosclerosis 226(1):129–133

    Article  CAS  PubMed  Google Scholar 

  16. Turkmen K, Ozbek O, Kayrak M, Samur C, Guler I, Tonbul HZ (2013) Peri-aortic fat tissue thickness in peritoneal dialysis patients. Perit Dial Int 33(3):316–324

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Colak H, Kilicarslan B, Tekce H, Tanrisev M, Tugmen C, Aktas G, Kursat S (2015) Relationship between epicardial adipose tissue, inflammation and volume markers in hemodialysis and transplant patients. Ther Apher Dial 19(1):56–62

    Article  CAS  PubMed  Google Scholar 

  18. Burtis CA, Ashwood ER. (1994) Tietz textbook of clinical chemistry, ed 2, Philadelphia, WB Saunders

  19. Lolekha PH, Chittamma A, Roberts WL, Sritara P, Cheepudomwit S, Suriyawongpaisal P (2005) Comparative study of two automated high-sensitivity C-reactive protein methods in a large population. Clin Biochem 38(1):31–35

    Article  CAS  PubMed  Google Scholar 

  20. Gutiérrez G, Jou JM, Carlos Reverter J, Martínez-Brotons F, Domingo A, Antonio Iriarte J, Remacha A, Rey J, Vives Corrons JL (1996) standardization committee for haematology. External quality assurance program for general hematology. Evaluation of the 1994 results. Sangre (Barc) 41(2):115–123

    Google Scholar 

  21. Reiner E, Svedruzic D, Simeon-Rudolf V, Lipovac V, Gavella M, Mrzljak V (1999) Paraoxonase and arylesterase activities in the serum of two hyperlipoproteinaemic patients after repeated extracorporal lipid precipitation. Chem Biol Interact 14(119–120):405–411

    Article  Google Scholar 

  22. Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Di Mario U, Leonetti F (2003) Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 11:304–310

    Article  PubMed  Google Scholar 

  23. Silaghi AC, Poant L, Valea A, Pais R, Silaghi H (2011) Is epicardial adipose tissue, assessed by echocardiography, a reliable method for visceral adipose tissue prediction? Med Ultrason 13:15–20

    PubMed  Google Scholar 

  24. Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappaterreno A, Di Mario U, Leonetti F (2003) Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 88:5163–5168

    Article  CAS  PubMed  Google Scholar 

  25. Kasiske BL (1988) Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 84(6):985–992

    Article  CAS  PubMed  Google Scholar 

  26. Miller NE (1987) Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J 113(2 Pt 2):589–597

    Article  CAS  PubMed  Google Scholar 

  27. Parthasarathy S, Barnett J, Fong LG (1990) High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1044(2):275–283

    Article  CAS  PubMed  Google Scholar 

  28. Draganov DI, La Du BN (2004) Pharmacogenetics of paraoxonases: a brief review. Naunyn Schmiedebergs Arch Pharmacol 369(1):78–88

    Article  CAS  PubMed  Google Scholar 

  29. Bełtowski J, Wójcicka G, Jamroz A (2003) Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia. Atherosclerosis 170(1):21–29

    Article  PubMed  Google Scholar 

  30. Patra SK, Singh K, Singh R (2013) Paraoxonase 1: a better atherosclerotic risk predictor than HDL in type 2 diabetes mellitus. Diabetes Metab Syndr 7(2):108–111

    Article  PubMed  Google Scholar 

  31. Mackness MI, Mackness B, Durrington PN (2002) Paraoxonase and coronary heart disease. Atheroscler Suppl 3(4):49–55

    Article  CAS  PubMed  Google Scholar 

  32. Hasselwander O, Savage DA, McMaster D, Loughrey CM, McNamee PT, Middleton D, Nicholls DP, Maxwell AP, Young IS (1999) Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients. Kidney Int 56(1):289–298

    Article  CAS  PubMed  Google Scholar 

  33. Paragh G, Asztalos L, Seres I, Balogh Z, Löcsey L, Kárpáti I, Mátyus J, Katona E, Harangi M, Kakuk G (1999) Serum paraoxonase activity changes in uremic and kidney-transplanted patients. Nephron 83(2):126–131

    Article  CAS  PubMed  Google Scholar 

  34. Iacobellis G, Bianco AC (2011) Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends Endocrinol Metab 22:450–457

    Article  CAS  PubMed  Google Scholar 

  35. Cetin M, Cakici M, Polat M, Suner A, Zencir C, Ardic I (2013) Relation of epicardial fat thickness with carotid intima-media thickness in patients with type 2 diabetes mellitus. Int J Endocrinol 2013:769175

    PubMed Central  PubMed  Google Scholar 

  36. Natale F, Tedesco MA, Mocerino R, de Simone V, Di Marco GM, Aronne L, Credendino M, Siniscalchi C, Calabrò P, Cotrufo M, Calabrò R (2009) Visceral adiposity and arterial stiffness: echocardiographic epicardial fat thickness reflects, better than waist circumference, carotid arterial stiffness in a large population of hypertensives. Eur J Echocardiogr 10(4):549–555

    Article  PubMed  Google Scholar 

  37. Turkmen K, Kayikcioglu H, Ozbek O, Solak Y, Kayrak M, Samur C, Anil M, Zeki Tonbul H (2011) The relationship between epicardial adipose tissue and malnutrition, inflammation, atherosclerosis/calcification syndrome in ESRD patients. Clin J Am Soc Nephrol 6(8):1920–1925

    Article  PubMed Central  PubMed  Google Scholar 

  38. D’Marco LG, Bellasi A, Kim S, Chen Z, Block GA, Raggi P (2013) Epicardial adipose tissue predicts mortality in incident hemodialysis patients: a substudy of the Renagel in New Dialysis trial. Nephrol Dial Transplant 28(10):2586–2595

    Article  PubMed  Google Scholar 

  39. Karohl C, D’Marco L, Bellasi A, Raggi P (2013) Hybrid myocardial imaging for risk stratification prior to kidney transplantation: added value of coronary calcium and epicardial adipose tissue. J Nucl Cardiol 20(6):1013–1020

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eray Eroglu.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eroglu, E., Kocyigit, I., Unal, A. et al. Serum paraoxonase activity is associated with epicardial fat tissue in renal transplant recipients. Int Urol Nephrol 47, 1409–1414 (2015). https://doi.org/10.1007/s11255-015-1051-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-015-1051-8

Keywords

Navigation